Skip to main content
Premium Trial:

Request an Annual Quote

Richard Brennan

Premium
GeneGo has tapped Richard Brennan as director of toxicology, a role that will include running the MetaTox Consortium, a public/private systems biology collaborative, the company said last week.
 
Brennan previously was director of molecular and investigative toxicology at Iconix Biosciences, an associate director of pharmacology and cell biology at Cornerstone Pharmaceuticals, and a senior scientist at OSI Pharmaceuticals.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.